About HELIXOMER, INC.
Helixomer is a preclinical drug design and development company that utilizes its patented RNA origami (RNAO) platform coupled with aptamers to create highly effective nanodrugs for addressing difficult unmet healthcare needs.
Drug design and developmentRNA origami (RNAO) platform utilizationAptamer integration for pharmaceutical solutions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to HELIXOMER, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.